Learn / Clinical Research Management / Close-out, transparency and professional practice
Transparency: registration, results and publication
12 minute read · 6-question quiz
What you will learn
Explain why trials must be registered and results shared
Name the main trial registries and when registration is due
Apply authorship and publication ethics (ICMJE) and data sharing principles
Trial results belong to participants and the public as well as to sponsors. Without transparency, only positive results are published and clinicians make decisions on incomplete evidence, a problem known as publication bias.
Registration
Registering a trial in a public registry before the first participant is enrolled records the question, design and planned outcomes, so that later changes can be seen.
- ClinicalTrials.gov (United States).
- WHO International Clinical Trials Registry Platform (ICTRP), which gathers records from national and regional registries.
- Pan African Clinical Trial Registry (PACTR), widely used in Africa.
- EU Clinical Trials Register and others.
The International Committee of Medical Journal Editors (ICMJE) requires prospective registration as a condition of publishing in member journals. Many regulators and funders also require it.
Results reporting
- Results summaries must be posted in registries within the period set by law or policy (for example, within 12 months of completion in several systems; check current requirements).
- The clinical study report goes to regulators.
- Lay summaries make results accessible to participants and the public.
- Negative and inconclusive results must be reported too.
Authorship and publication ethics
The ICMJE criteria say an author must meet all four:
- Substantial contributions to design, data collection, analysis or interpretation.
- Drafting or critically revising the work.
- Final approval of the version to be published.
- Accountability for all aspects of the work.
Others who contribute (for example, data entry staff or an editor) are acknowledged. Ghost authorship (a hidden writer) and gift authorship (an author with no real contribution) are misconduct. Sponsors should not control the content of publications in ways that hide results, and contracts should protect the right to publish.
The CONSORT statement guides reporting of randomised trials, with a flow diagram of participants, and SPIRIT guides protocol content. Conflicts of interest and funding must be disclosed.
Data sharing
Sharing de-identified participant data, with proper governance, allows others to verify and re-use results. Data sharing plans, consent wording and privacy protections should be designed from the start.
Summary
Trials are registered before enrolment and results are reported in registries and publications.
ClinicalTrials.gov, WHO ICTRP and PACTR are major registries; ICMJE requires prospective registration.
Authorship requires all four ICMJE criteria; ghost and gift authorship are misconduct.
Reporting negative results and sharing data support trustworthy evidence.
Check your understanding
Draft study guide. Spotted an error or something unclear? Tell us at hello@scintria.com. This is educational material, not clinical or regulatory advice.